Church & Dwight (CHD) vs Clorox (CLX): Diverging Paths in Consumer Staples
Key Takeaways
- Church & Dwight (CHD) is gaining market share on volume-led organic sales growth, while Clorox (CLX) is working through an ERP (enterprise resource planning) transition that is temporarily distorting its results.
- CHD trades at a premium valuation with modest dividend yield, whereas CLX screens as a cheaper, higher-yielding stock with a steeper recent drawdown.
- Relative performance has diverged sharply: CHD is positive year to date, while CLX has underperformed the broader consumer staples sector.
- Both companies face inflation, tariff, and promotional-cost pressures, but their near-term catalysts and momentum profiles point in different directions.
Setting the Stage for These Two Staples Names
Church & Dwight and Clorox are two well-known names in the household and personal care products industry, but they occupy meaningfully different positions in the current market. This stock comparison is useful for investors and traders evaluating how two consumer staples businesses with distinct growth profiles, valuation multiples, and risk factors stack up against one another. While both operate in defensive categories such as cleaning, laundry, and health products, their recent momentum, market positioning, and sentiment have diverged. The analysis below reviews each company's business context, recent relative performance, and the factors currently shaping investor expectations. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
Church & Dwight Overview and Recent Performance
CHD, or Church & Dwight Co., Inc., is the leading U.S. producer of baking soda and owns brands including Arm & Hammer, OxiClean, TheraBreath, Hero, Batiste, and Touchland. The company derives roughly 80% of its sales from the U.S. and has been reshaping its portfolio by exiting slower-growing businesses, such as its vitamin brands, while acquiring faster-growing assets including hand-sanitizer maker Touchland and stain-removal brand Miss Mouth's Messy Eater.
In recent market activity, CHD has shown resilience but has not been immune to selling pressure. The stock delivered positive year-to-date gains, supported by strong quarterly results that featured organic sales growth well above management's initial guidance, driven by volume. However, in recent weeks the shares pulled back from their highs amid a broader pause in momentum. Analysts have cited a premium valuation—roughly 26 times forward earnings—as a key consideration, even as the company's gross margin expansion and 30th consecutive annual dividend increase underscore its financial discipline. From what I see, the company’s consistent execution stands out here.
Clorox Overview and Recent Performance
CLX, or The Clorox Company, manufactures cleaning, disinfecting, food, and personal care products under brands such as Clorox, Pine-Sol, Glad, Fresh Step, Hidden Valley, Brita, and Burt's Bees. The company recently completed the final phase of its U.S. ERP (enterprise resource planning) system rollout and closed its acquisition of GOJO Industries, owner of the Purell hand-sanitizer brand.
Clorox's recent stock behavior has been notably weak. The shares have fallen sharply over recent months and trade below their 50-day and 200-day moving averages. Much of the decline reflects transitory factors: retailers drew down inventory that had been built up ahead of the ERP transition, weighing on reported sales and earnings, and the company issued a voluntary product recall during the period. The stock now offers a dividend yield near 6%, reflecting both a higher payout and a lower share price. Analysts hold a predominantly "Hold" consensus rating as the market weighs these short-term disruptions against the company's longer-term transformation efforts. I’m watching this closely as the ERP issues work through the system.
Head-to-Head Comparison
The two companies diverge most clearly on growth trajectory and valuation. CHD is oriented around volume-led organic growth, premiumization, and disciplined acquisitions in faster-moving categories such as oral care and acne treatment. Its shares command a higher earnings multiple—reflecting that growth expectation—but pay a comparatively small dividend. CLX, by contrast, is a more mature, cash-generative business whose near-term results are distorted by the ERP transition and inventory drawdown. It trades at a lower earnings multiple and carries a much higher dividend yield, though the elevated payout has at times absorbed nearly all of its free cash flow.
Risk profiles also differ. CLX faces balance-sheet leverage and tighter dividend coverage following its GOJO acquisition, along with concentrated exposure to categories showing soft demand. CHD's main risks center on premium valuation, rising marketing costs, and competitive pressure from private-label brands. In terms of market sentiment, CHD has held up better despite a recent pullback, while CLX's technical posture remains bearish relative to the staples sector.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would currently lean toward CHD. The company's relative strength lies in more consistent trend behavior, volume-led organic growth, expanding margins, and a steadier earnings trajectory. CLX, while inexpensive on a valuation basis and offering a compelling dividend yield, is contending with transitory operational disruptions, weaker relative momentum, and higher balance-sheet risk. This assessment is probabilistic rather than definitive: it reflects current momentum, stability, and positioning, and could shift as Clorox's ERP-related headwinds fade and its GOJO integration matures.
Exploring AI-Assisted Trading Approaches
In my own analysis process, I sometimes look at Tickeron’s AI Trading Bots to see how automated strategies align with names like these. The platform’s Trending AI Robots section highlights bots whose performance and risk parameters fit current market conditions, offering a range of styles from short-term swings to longer-term trends. It’s one way to cross-check ideas without replacing core fundamental work.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CLX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CLX turned positive on October 05, 2026. Looking at past instances where CLX's MACD turned positive, the stock continued to rise in 29 of 48 cases over the following month. The odds of a continued upward trend are 60%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLX's RSI Indicator exited the oversold zone, 21 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 56 cases where CLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 54%.
Following a +3.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLX advanced for three days, in 184 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
Bearish Trend Analysis
CLX moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLX crossed bearishly below the 50-day moving average on September 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for CLX entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. CLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLX's P/B Ratio (109.890) is slightly higher than the industry average of (18.044). P/E Ratio (16.927) is within average values for comparable stocks, (43.673). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.518). CLX has a moderately high Dividend Yield (0.061) as compared to the industry average of (0.024). P/S Ratio (1.542) is also within normal values, averaging (1.931).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of detergent and cleaning products
Industry HouseholdPersonalCare
Advertisement